Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Neurology therapeutics Market Research Reports

Titlepublishedprice

Dyskinesia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ctive of the Dyskinesia Report is to understand the market and pipeline status of the drugs around the Dyskinesia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strate......"
01-Sep-2016$2000

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Absence Seizure Report is to understand the market and pipeline status of the drugs around the Absence Seizure to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing ......"
01-Sep-2016$2000

Encephalopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Encephalopathy Report is to understand the market and pipeline status of the drugs around the Encephalopathy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Neuropathic  Pain - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Neuropathic Pain forecasted market share for ten years to 2023 segmented by ......"
01-Sep-2016$4950

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... nited States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Epilepsy forecasted market share for ten years to 2023 segmented by seven major market......"
01-Sep-2016$4950

Generalized Tonic-Clonic Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... the globe. A key objective of the Generalized Tonic-Clonic Seizure Report is to understand the market and pipeline status of the drugs around the Generalized Tonic-Clonic Seizure to explore the generic development opportunities, licensing opportunit......"
01-Sep-2016$2000

Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... acturers across the globe. A key objective of the Attention Deficit Hyperactivity Disorder (ADHD) Report is to understand the market and pipeline status of the drugs around the Attention Deficit Hyperactivity Disorder (ADHD) to explore the generic de......"
01-Sep-2016$2000

Migraine  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... nited States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Migraine forecasted market share for ten years to 2023 segmented by seven major market......"
01-Sep-2016$4950

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... e seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Amyotrophic lateral sclerosis (ALS) forecasted market share......"
01-Sep-2016$4950

Brain Hemorrhage - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ts ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Brain Hemorrhage forecasted market share for ten years to 2023 segmented by se......"
01-Sep-2016$4950